Email Page

Related Practices

Axinn’s FDA Practice Group provides counseling, FDA representation and litigation services relating to the development, approval, exclusivity and marketing of new and generic drug products, biologics, medical devices, human tissue products, veterinary products and tobacco products.  By coupling knowledge of the complex and shifting FDA regulatory landscape with the firm’s scientific capability and patent litigation, antitrust and licensing expertise, the firm offers a comprehensive team to enable companies to develop product life cycle development strategies, to bring regulated products to market and to defend market positions such as exclusivity periods in the most efficient, competitive and profitable manner.

Representative experience includes:


Articles & Newsletters